CLINICAL_TRIALS trial_result · 2014-08-25

Clinical Trial Update: An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext [Phase 2]

An extension Phase 2 study of Proellex (telapristone acetate) in women with uterine fibroids was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 2 | Status: TERMINATED | Results posted: 2014-08-25